- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Patent holdings for IPC class C07K 16/30
Total number of patents in this class: 12498
10-year publication summary
|
1038
|
1082
|
1101
|
1138
|
1067
|
1086
|
1038
|
1069
|
905
|
502
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1127 |
416 |
| Genentech, Inc. | 4099 |
203 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
184 |
| Hoffmann-La Roche Inc. | 3783 |
160 |
| The Regents of the University of California | 20720 |
158 |
| Memorial Sloan-Kettering Cancer Center | 2038 |
141 |
| F. Hoffmann-La Roche AG | 7836 |
139 |
| Amgen Inc. | 4425 |
135 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
135 |
| The Trustees of the University of Pennsylvania | 4414 |
126 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
119 |
| Janssen Biotech, Inc. | 1762 |
119 |
| Amgen Research (Munich) GmbH | 260 |
102 |
| Novartis AG | 10263 |
95 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
93 |
| Board of Regents, The University of Texas System | 6102 |
91 |
| SeaGen Inc | 533 |
87 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
85 |
| Daiichi Sankyo Company, Limited | 1893 |
83 |
| Immunomedics, Inc. | 239 |
83 |
| Other owners | 9744 |